We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current HRMY market cap is 1.66B. The company's latest EPS is USD 2.2698 and P/E is 12.93.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 117.21M | 128.31M | 119.13M | 134.22M | 160.27M |
| Operating Income | 11.9M | 47.61M | 40.42M | 46.9M | 64.36M |
| Net Income | 87.94M | 48.51M | 29.49M | 34.3M | 38.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6M | 159.74M | 305.44M | 437.86M | 582.02M |
| Operating Income | -145.9M | 16.99M | 87.53M | 120.19M | 192.03M |
| Net Income | -187.21M | -63.85M | 34.6M | 181.47M | 128.85M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 643.46M | 673.87M | 715.09M | 760.18M | 777.77M |
| Total Liabilities | 299.58M | 271.03M | 272.05M | 275.01M | 296.43M |
| Total Equity | 343.88M | 402.84M | 443.04M | 485.17M | 481.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 106.7M | 427.07M | 433.44M | 673.87M | 811.45M |
| Total Liabilities | 118.29M | 329.89M | 246.94M | 271.03M | 344.46M |
| Total Equity | -422.86M | 97.18M | 186.51M | 402.84M | 466.99M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 117.79M | 144.47M | 42.56M | 79.07M | 142.72M |
| Investing | -94.94M | -141.83M | -1.79M | -9.56M | -10.37M |
| Financing | 4.18M | 6.84M | 3.41M | 3.07M | -52.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.44M | -2.99M | 98.56M | 144.47M | 219.39M |
| Investing | -127.15M | -2M | -100.3M | -141.83M | -46.44M |
| Financing | 143.77M | 209.16M | 7.42M | 6.84M | -105.55M |
| Market Cap | 1.66B |
| Price to Earnings Ratio | 12.93 |
| Price to Sales Ratio | 2.86 |
| Price to Cash Ratio | 5.34 |
| Price to Book Ratio | 3.57 |
| Dividend Yield | - |
| Shares Outstanding | 56.77M |
| Average Volume (1 week) | 359.41k |
| Average Volume (1 Month) | 389.89k |
| 52 Week Change | -7.83% |
| 52 Week High | 39.265 |
| 52 Week Low | 18.6112 |
| Spread (Intraday) | 2.2 (7.24%) |
| Company Name | Harmony Biosciences Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.harmonybiosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
